SDP has received research funding from AstraZeneca, Boehringer Ingelheim, Novartis Pharmaceuticals Co., and Merck Sharpe & Dohme, and is a consultant for or has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Laboratoires Servier, Merck Sharp & Dohme, Novartis Pharmaceuticals Co., Novo Nordisk, Sanofi, and Takeda
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome
Fat Metabolism and Mitochondrial Health Your mitochondria are the "power plants" of your cells
Keeping up with routine wellness, including flu and COVID vaccinations, is also highly recommended while undergoing any significant medical treatment
Outcomes: Studies reporting incident gastrointestinal cancers (colorectal, pancreatic, gastric, liver, or biliary tract cancers), either as primary, secondary, or safety out-comes